BioMarin Pharmaceutical Inc. (BMRN) Profit Margin
BioMarin Pharmaceutical Inc. (BMRN) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -56.43% |
| 2017-12-31 | -8.91% |
| 2018-12-31 | -5.18% |
| 2019-12-31 | -1.40% |
| 2020-12-31 | 45.90% |
| 2021-12-31 | -3.47% |
| 2022-12-31 | 6.75% |
| 2023-12-31 | 6.93% |
| 2024-12-31 | 14.96% |
| 2025-12-31 | 10.83% |
How BMRN compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| IQV | IQVIA Holdings Inc. | 8.34% |
| ENSG | The Ensign Group Inc. | 6.80% |
| ADUS | Addus HomeCare Corporation | 6.74% |
| VCEL | Vericel Corporation | 5.98% |
| USPH | U.S. Physical Therapy Inc. | 5.07% |
These are five companies in the same sector as BMRN with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get BioMarin Pharmaceutical Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("BMRN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BMRN | $66.97 | +3.29% | 2.52M |
| 3 | ||||
| 4 | ||||
| 5 |